Sarah J. Tabrizi

Huntington's disease: from molecular pathogenesis to clinical treatment

Christopher A. Ross, Sarah J. Tabrizi · The Lancet Neurology · 2010 · 1.7K citations

Molecular Pathogenesis, Genetics, Degenerative Disease +3

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

Sarah J. Tabrizi, Douglas R. Langbehn, Blair R. Leavitt et al. · The Lancet Neurology · 2009 · 959 citations

Neurodegenerative Diseases, Dementia, Longitudinal Track-hd Study +8

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data

Sarah J. Tabrizi, Rachael I. Scahill, Gail Owen et al. · The Lancet Neurology · 2013 · 822 citations

Neurodegenerative Diseases, Early-stage Huntington, Genetic Epidemiology +6

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

Maria Björkqvist, Edward J. Wild, Jenny Thiele et al. · The Journal of Experimental Medicine · 2008 · 629 citations · Full text

Novel Pathogenic Pathway, Immune Activation Detectable, Immune Activation +22

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

Sarah J. Tabrizi, Rachael I. Scahill, Alexandra Dürr et al. · The Lancet Neurology · 2010 · 592 citations

Early Stage Huntington, Degenerative Disease, Track-hd Study +6